Filing Flows › Mirum Pharmaceuticals (MIRM) › Recalls, complaints & regulation
Mirum Pharmaceuticals (MIRM): clinical trials
Mirum Pharmaceuticals (MIRM) beyond its filings: 12 active clinical trials.
Mirum Pharmaceuticals' latest quarter
Mirum Pharmaceuticals, Q3 2026: revenue $186M (+40% year over year), operating margin -32.2%, net loss $40.8M, operating cash flow −$4.3M. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does Mirum Pharmaceuticals have?
12 active studies on ClinicalTrials.gov, 5 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.